{'fraction_non_alphanumeric': 0.01988400994200497, 'fraction_numerical': 0.0, 'mean_word_length': 5.824858757062147, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Digital-microfluidic biochips for quantitative analysis: Bridging the Gap between microfluidics and microbiology

Digital-microfluidics technology has shown considerable promise for advancing sample preparation and point-of-care diagnostics; therefore, it has the potential to transform microbiology and biochemistry research. Over the past decade, a number of microfluidics design-automation techniques have been developed for on-chip droplet manipulation. However, these methods overlook the myriad complexities of biomolecular protocols and they have yet to make a significant impact in biochemistry/microbiology research. A paradigm shift in biochip design automation and a “phase transition” in research are clearly needed to bridge this gap between microfluidics and microbiology. In this paper, we explain how researchers from design-automation and embedded systems can play a key role in this transition. We present a new synthesis flow that uses realistic models of biomolecular protocols and cyberphysical adaptation to address real-world microbiology applications. We also present a list of metrics that can be used for the assessment of designautomation techniques for microbiology applications.